As part of the recent launch of Pioneering Pathways, we’re excited to share the second episode in the interactive series. This episode delves into our investigational neuroscience pipeline asset via an animated video showcasing the mechanism of action behind potential first-in-class fatty acid amide hydrolase, or FAAH inhibitors, which are currently being investigated with the aim to address the underlying pathophysiology of post-traumatic stress disorder (PTSD).
PTSD is a common psychiatric condition in which individuals who have been exposed to a stressful or traumatic event may experience powerful anxious responses that impact all aspects of their lives. Millions of people worldwide are impacted by PTSD, yet there are few treatment options centered around addressing how traumatic events and experience transform into a chronic mental disorder. Learn more about the symptoms, the latest science, and the daily difficulties of living with this complex condition here and watch this episode to learn about the innovative pathways we are exploring to address unmet patient needs.
1 Kessler RC, Aguilar-Gaxiola S, Alonso J, et al. Trauma and PTSD in the WHO world mental health surveys. Eur J of Psychotraumatol. 2017;8(sup5):1353383.
